Baoling Bio is a biomedical technology company engaged in innovative drug research and industrialization processes.
Baoling Bio is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2021 | Series A | ¥106.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
New Value Capital | — | Series A |